Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial.
CNS Drugs March 24, 2026 Mathieu Seynaeve, Fiona Dunbar, Chandni Hindocha et al.
Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial.